Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesExchange Rate EffectFree Cash FlowNet Cash FlowNet Income
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Gains from Investment Securities: 2019-2020

Historic Gains from Investment Securities for Burning Rock Biotech (BNR) over the last 1 years, with Dec 2020 value amounting to $234,000.

  • Burning Rock Biotech's Gains from Investment Securities fell 74.03% to $234,000 in Q4 2020 from the same period last year, while for Dec 2020 it was $2.2 million, marking a year-over-year change of. This contributed to the annual value of -$301,000 for FY2024, which is 111.97% down from last year.
  • Per Burning Rock Biotech's latest filing, its Gains from Investment Securities stood at $234,000 for Q4 2020, which was down 54.61% from $515,504 recorded in Q3 2020.
  • In the past 5 years, Burning Rock Biotech's Gains from Investment Securities registered a high of $900,943 during Q4 2019, and its lowest value of -$240,499 during Q3 2019.
  • Moreover, its 2-year median value for Gains from Investment Securities was $501,937 (2020), whereas its average is $382,377.
  • Within the past 5 years, the most significant YoY rise in Burning Rock Biotech's Gains from Investment Securities was 314.35% (2020), while the steepest drop was 74.03% (2020).
  • Quarterly analysis of 2 years shows Burning Rock Biotech's Gains from Investment Securities stood at $900,943 in 2019, then crashed by 74.03% to $234,000 in 2020.
  • Its last three reported values are $234,000 in Q4 2020, $515,504 for Q3 2020, and $501,937 during Q1 2020.